Fig. 1
TBK1/IKK? inhibition augments ?-cell regeneration in a zebrafish model of type 1 diabetes. (A, B, D?H) Bright-field images combined with fluorescent images showing the overall morphology and [Tg(ins:CFP-NTR)s892; Tg(ins:Kaede)jh6] expression (green) of larvae at 48 hpa treated with DMSO (A), BX795 (B), BX912 (D), amlexanox (E), AZ-5c (F), AZ-5e (G), and PIAA (H), respectively. While TBK1/IKK?-Is substantially expanded [Tg(ins:CFP-NTR)s892; Tg(ins:Kaede)jh6]-expressing cell population (white squares and insets) during regeneration (B and E?H) compared to DMSO (A), the PDPK1 inhibitor BX912 showed minimum effect (D). (C) BX795 is a dual inhibitor of PDPK1 and TBK1/IKK?. (I) Quantification of the number (mean?±?SD) of total regenerated ?-cells at 48 hpa (in A-B and D-H; 4.3?±?1.3 (DMSO), 9.0?±?2.2 (BX795), 4.7?±?1.2 (BX912), 11.0?±?3.4 (amlexanox), 7.4?±?1.4 (AZ-5c), 7.0?±?1.3 (AZ-5e), and 17.7?±?2.4 (PIAA)). Cells in 20 planes of confocal images from 25 individual larvae were counted per condition. ***P?<?0.001.